ArticleProtein & cell2017

CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.

Lixia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.